Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.69 |
| ▸ | CA1 | P00915 | 1/20 | 0.69 |
| ▸ | CA2 | P00918 | 1/20 | 0.69 |
| ▸ | CA7 | P43166 | 1/20 | 0.69 |
| ▸ | CA9 | Q16790 | 1/20 | 0.69 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | TTR | P02766 | 1/20 | 0.59 |
| ▸ | DPP4 | P27487 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | RAB9A | P51151 | 3/20 | 0.55 |
| ▸ | NPC1 | O15118 | 2/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | MAOB | P27338 | 1/20 | 0.54 |
| ▸ | BCHE | P06276 | 1/20 | 0.53 |
| ▸ | ACHE | P22303 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethyl 3-(4-Isopropylphenyl)Acrylate SCHEMBL526299 | 1.00 | CA12 (0.69) | CA12CA1CA2CA7CA9 | |
| Ethyl Cinnamate SCHEMBL28554385 | 0.90 | KDM4E (0.66) | CA12CA1CA2CA7CA9 | |
| Ethyl Cinnamate SCHEMBL28554384 | 0.90 | KDM4E (0.66) | CA12CA1CA2CA7CA9 | |
| Ethyl 3-(4-Isopropylphenyl)Acrylate SCHEMBL28182168 | 0.89 | PTGS2 (0.61) | CA12CA1CA2CA7CA9 | |
| Ethyl 3-(4-Isopropylphenyl)Acrylate SCHEMBL28182167 | 0.89 | PTGS2 (0.61) | CA12CA1CA2CA7CA9 | |
| SCHEMBL10939791 | 0.88 | CA12 (0.86) | CA12CA1CA2CA7CA9 | |
| SCHEMBL13957401 | 0.88 | CA12 (0.86) | CA12CA1CA2CA7CA9 | |
| SCHEMBL5059085 | 0.88 | CA12 (0.86) | CA12CA1CA2CA7CA9 | |
| SCHEMBL10904660 | 0.88 | CA12 (0.65) | CA12CA1CA2CA7CA9 | |
| SCHEMBL10904659 | 0.88 | CA12 (0.65) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1734 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190299032-A1 | Oil-In-Water Type Emulsion Cosmetic Composition | SHISEIDO COMPANY, LTD. (JP) | 2019-10-03 | — | — | US | claimed |
| CN-108172902-A | Ethyl acrylate class compound is used as electrolysis additive, electrolyte, secondary cell based on aluminum honeycomb and preparation method thereof | 深圳先进技术研究院 | 2018-06-15 | — | — | CN | claimed |
| US-20180056096-A1 | Oil-In-Water Type Emulsion Cosmetic Composition | SHISEIDO CO., LTD. (JP) | 2018-03-01 | — | — | US | claimed |
| US-20160128944-A1 | COATED PARTICLES AND COMPOSITIONS COMPRISING SAME | VYOME THERAPEUTICS LIMITED (IN) | 2016-05-12 | — | — | US | claimed |
| EP-3003031-A1 | COATED PARTICLES AND COMPOSITIONS COMPRISING SAME | Vyome Biosciences Pvt Ltd (IN) | 2016-04-13 | — | — | EP | claimed |
| CN-105407718-A | Coated particles and compositions comprising the same | VYOME BIOSCIENCES | 2016-03-16 | — | — | CN | claimed |
| WO-2014195872-A1 | COATED PARTICLES AND COMPOSITIONS COMPRISING SAME | VYOME BIOSCIENCES PVT. LTD. (IN) | 2014-12-11 | — | — | WO | claimed |
| US-8404258-B2 | External preparation for the skin | SHISEIDO COMPANY, LTD. (JP) | 2013-03-26 | — | — | US | claimed |
| CN-101282708-B | External preparation for skin containing a phosphorlated saccharide | EZAKI GLICO CO | 2013-03-20 | — | — | CN | claimed |
| US-8168227-B2 | Modified powder and cosmetic composition using the same | SHISEIDO CO., LTD. (JP) | 2012-05-01 | — | — | US | claimed |
| CN-1679475-B | Hair cosmetic composition | KAO CORP | 2010-06-16 | — | — | CN | claimed |
| US-20100047185-A1 | ACTVIE SUBSTANCE COMBINATION | ISDIN S.A. (ES) | 2010-02-25 | — | — | US | claimed |
| WO-2008083975-A1 | LIGHT-STABILIZED COMPOSITION | ISDIN S.A. (ES) | 2008-07-17 | — | — | WO | claimed |
| WO-2008083974-A1 | ACTIVE SUBSTANCE COMBINATION | ISDIN S.A. (ES) | 2008-07-17 | — | — | WO | claimed |
| WO-2008067928-A1 | UV ABSORBING COMPOSITIONS CONTAINING A PYRROLYLTRIAZINE | ISDIN S.A. (ES) | 2008-06-12 | — | — | WO | claimed |
| US-20070253989-A1 | Modified Powder and Cosmetic Composition Using the Same | SHISEIDO CO., LTD. (JP) | 2007-11-01 | — | — | US | claimed |
| US-20020131939-A1 | Hair protection compositions | ROCHE VITAMINS INC. | 2002-09-19 | — | — | US | claimed |
| US-20260076892-A1 | GEL COMPOSITION AND OIL-IN-WATER COMPOSITION | SHISEIDO COMPANY, LTD. (JP) | 2026-03-19 | — | — | US | disclosed |
| EP-0211183-A2 | Use of ubidecarenone(ubiquinone-10) as an antichromatotic agent | Eisai Co., Ltd. (JP) | 1987-02-25 | — | — | EP | disclosed |
| US-4284621-A | SUNSCREEN FOR SKIN | BAYER AKTIENGESELLSCHAFT (DE) | 1981-08-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260076892-A1 | GEL COMPOSITION AND OIL-IN-WATER COMPOSITION | SGMS1, SGMS2, CETP | CA12 1871/4885CA1 2478/4885CA2 3961/4885 |
| US-20190299032-A1 | Oil-In-Water Type Emulsion Cosmetic Composition | CD44, DSG1, CUTA | CA12 862/4885CA1 1970/4885CA2 2323/4885 |
| US-20100047185-A1 | ACTVIE SUBSTANCE COMBINATION | UGT2B17, TACR2, UGT1A1 | CA12 1110/4885CA1 2294/4885CA2 3587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.